Viewing nowCrelorush 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Sama Pharmaceuticals Co., Ltd.

MFDS item code 201001010 · Notified 2010.01.28 · Insurance code 645702140
Improves dyslipidemia, slows the progression of atherosclerosis, and prevents cardiovascular disease
This medication is used for the treatment of hypercholesterolemia and various forms of dyslipidemia. It helps in the treatment of primary hypercholesterolemia and mixed hyperlipidemia patients whose condition cannot be controlled by diet and exercise, and is particularly effective for patients with familial hypercholesterolemia. It also lowers total cholesterol and LDL cholesterol levels in patients at high risk of cardiovascular disease, delaying the progression of atherosclerosis. It can be used as an adjunct to diet in pediatric patients aged 10 to 17 who meet certain criteria. Furthermore, it helps in reducing the risks of cardiovascular diseases, strokes, and myocardial infarctions. Overall, this medication is used to improve dyslipidemia and lower the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg daily. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race : Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medication is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be individualized for each patient according to the recommended treatment goals. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, those with allergies to its components, severely impaired liver function, neuromuscular disease, severe kidney impairment, and women who are pregnant or breastfeeding should not use it. Moreover, women who may become pregnant should ensure that they are highly unlikely to be pregnant before taking this medication and should use appropriate contraceptive methods. Careful use is required in patients at risk of neuromuscular disorders, such as those with slight kidney impairment, hypothyroid patients, patients with a family history of neuromuscular disorders, alcoholics, or those taking certain concurrent medications, potentially requiring dose adjustments or regular monitoring. Since this medication contains lactose, patients with lactose intolerance or related genetic disorders should not take it. Regular monitoring of liver function and muscle condition is necessary while on this medication, and immediate consultation with healthcare providers is required if symptoms such as muscle pain, weakness, fatigue, or fever occur. Additionally, this medication may interact with other drugs, so patients taking other medications must inform their healthcare providers, especially when used in combination with specific antiviral agents, immunosuppressants, and fibrate-class drugs. During pregnancy or breastfeeding, this medication should not be used, and women planning to become pregnant should consult before use. In the case of overdose, as no specific antidote exists, immediate medical attention should be sought for appropriate treatment and evaluation. Caution is needed while driving or operating machinery, as dizziness may occur. Lastly, this medication may show higher plasma concentrations in Asians, leading to a need for dose adjustments.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, drug eruption resembling psoriasis, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container as it may be sensitive to air and moisture. Additionally, it is important to keep it in a cool place at or below 30 degrees Celsius to maintain its efficacy.
Yellow round film-coated tablet
30 tablets (10 tablets/alu-alu X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Sama Pharmaceuticals Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.